Source: Annual Congress 2009 - Asthma and comorbid conditions



Rating:

Share or cite this content

Citations should be made in the following way:
D. Ozol, C. Koca, R. Akgedik, M. Aydin, Z. Yildirim, R. Yigitoglu (Ankara, Turkey). Prevalence of metabolic syndrome in women asthma patients: role of adipokines. Eur Respir J 2009; 34: Suppl. 53, 3412

Member's Comments

No comment yet.

Related content which might interest you: The association between metabolic syndrome, obesity and asthma Source: Annual Congress 2008 - Risk factors for allergic asthma and allergic rhinitis Year: 2008 Prevalence of metabolic syndrome in smokers with and without COPD Source: Annual Congress 2008 - COPD and miscellaneous Year: 2008 Prevalence and clinical characteristics of metabolic syndrome in underweight and normal weight patients with COPD Source: Annual Congress 2010 - Pulmonary rehabilitation and chronic care: new developments in interventions, assessment and care Year: 2010 Metabolic syndrome in COPD patients without cardiovascular comorbidities: Co-existence or a different COPD phenotype? Source: Annual Congress 2010 - COPD: phenotyping and monitoring Year: 2010 Is OSA an important risk factor for metabolic dysregulation in obese COPD patients Source: International Congress 2018 – From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS) Year: 2018 Features of adipokine regulation at young patients with bronchial asthma with different phenotypes of obesity Source: International Congress 2019 – Understanding the mechanisms underlying airway diseases Year: 2019 The role of obesity in patients with sarcoidosis Source: International Congress 2019 – Granulomatous disorders: pathogenesis, epidemiology and clinical issues Year: 2019 Evaluation of association between COPD and metabolic syndrome, and insulin resistance Source: Annual Congress 2012 - COPD comorbidities II Year: 2012 Metabolic syndrome in patients with COPD and their association with systemic inflammation Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015 Impact of pulmonary function on cardiovascular disease events in persons with metabolic syndrome and diabetes Source: Annual Congress 2011 - Comorbidities and impact on society of asthma and COPD Year: 2011 Clinical differences of COPD patients with and without metabolic syndrome Source: Annual Congress 2010 - COPD: comorbidities Year: 2010 Prevalence of the metabolic syndrome (MS) in mediterranean patients with suspected OSAS Source: Annual Congress 2008 - Socioepidemiological studies in obstructive sleep apnoea Year: 2008 Comorbidities in asthma: the role of obesity in children with asthma Source: Virtual Congress 2020 – Which paediatric asthma guidelines are the most appropriate for children and adolescents? Year: 2020 Mechanisms of exacerbation of respiratory symptoms in patients with metabolic syndrome Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases Year: 2006 Determining factors for the altered adipokine metabolism in women with COPD Source: Annual Congress 2010 - Rehabilitation: more than just exercise Year: 2010 Prevalence and diagnosis of obesity hypoventilation syndrome (OHS) in ambulatory obese patients Source: International Congress 2016 – Epidemiological aspects of obstructive sleep apnoea Year: 2016 Effect of obesity and metabolic syndrome in patients with bronchial asthma Source: International Congress 2015 – Clinical assessment in asthma and COPD Year: 2015 Metabolic consequences of obesity as an “outside in” mechanism of disease severity in asthma Source: Eur Respir J 2016; 48: 291-293 Year: 2016 IgE-autoantibodies and adipokines in patients with bronchial asthma and obesity Source: Annual Congress 2012 - Clinical diagnosis and treatment of adult asthma Year: 2012 COVID-19: Impact in adult patients with premorbid disease: Metabolic diseases (diabetes, obesity) Source: ERS Course 2021 - COVID-19: State of the art Year: 2021